| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/01/2008 | US7394003 Plants and seeds of corn variety LH333BT1 |
| 07/01/2008 | US7393998 Commercial production of insulin and insulin-like proteins in plants |
| 07/01/2008 | US7393997 Methods for modification of plant inflorescence architecture |
| 07/01/2008 | US7393948 increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants |
| 07/01/2008 | US7393945 Estrogen receptor genes and utilization thereof |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393943 for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis |
| 07/01/2008 | US7393941 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/01/2008 | US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
| 07/01/2008 | US7393830 Prolactin induced increase in neural stem cell numbers |
| 07/01/2008 | US7393823 isolated polypeptide, glycosylated polypeptide and monoclonal antibody and their combinations; binds to the extracellular domain of EGF receptor |
| 07/01/2008 | US7393687 Biomimetic 3-dimensional scaffold with metabolic stream separation for bioartificial liver device |
| 07/01/2008 | US7393686 Converting stem cells into ventral neurons, used for treatment of neurodegenerative and muscular disorders |
| 07/01/2008 | US7393685 culturing cells for analysis |
| 07/01/2008 | US7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
| 07/01/2008 | US7393683 Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 07/01/2008 | US7393679 Enzyme for degrading hyaluronic acid to amino acid; genetic engineered gene |
| 07/01/2008 | US7393671 Mutant carotenoid ketolases |
| 07/01/2008 | US7393661 Nucleic acids encoding OBG3 polypeptides |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 07/01/2008 | US7393648 Hybrid antibodies |
| 07/01/2008 | US7393632 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 07/01/2008 | US7393629 Via natural locomotion after alignment; use in biopsies |
| 07/01/2008 | US7393628 Method for enriching adherent monocyte populations |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
| 06/28/2008 | CA2616567A1 Stable differentiation of adult stem cells |
| 06/26/2008 | WO2008076961A1 Nitric oxide increases switching of t cells into t regulatory cells |
| 06/26/2008 | WO2008076857A2 Method and compositions for inhibiting mage protein interaction with kap-1 |
| 06/26/2008 | WO2008076844A2 Novel genes and rna molecules that confer stress tolerance |
| 06/26/2008 | WO2008076556A2 Generation of inner ear cells |
| 06/26/2008 | WO2008076435A1 Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008075378A2 Xeno-free culture conditions for human embryonic stem cells and methods thereof |
| 06/26/2008 | WO2008075377A2 Germ lineage derived feeder cells and methods thereof |
| 06/26/2008 | WO2008075339A2 Scaffolding for tissue regeneration or repair |
| 06/26/2008 | WO2008075206A2 Cell-matrix microspheres, methods for preparation and applications |
| 06/26/2008 | WO2008074840A2 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 06/26/2008 | WO2008074839A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | WO2008052740A3 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours |
| 06/26/2008 | WO2008051852A3 Extracellular matrix cancer vaccine adjuvant |
| 06/26/2008 | WO2008051612A9 Light-mediated anti-cell proliferative compositions and methods |
| 06/26/2008 | WO2008051265A9 Engineered cell growth on polymeric films and biotechnological applications there of |
| 06/26/2008 | WO2008036349A3 Fused stem cells useful for the treatment of diabetes and methods thereof |
| 06/26/2008 | WO2007146678A8 Method for selection of transformed cells |
| 06/26/2008 | WO2007143204A3 Compositions and methods for modifying cell surface glycans |
| 06/26/2008 | WO2007121345A3 Biomaterial implants |
| 06/26/2008 | WO2007082177A3 Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity |
| 06/26/2008 | WO2007067809A3 Methods of identifying agents that modulate mitochondrial function |
| 06/26/2008 | WO2006026570A8 Use of stem cells to generate inner ear cells |
| 06/26/2008 | WO2005076981A3 Methods and compositions related to neuronal differentiation |
| 06/26/2008 | US20080155716 Serine hydroxymethyltransferase as target for herbicides |
| 06/26/2008 | US20080155715 Stress-Responsive Root-Specific Genes |
| 06/26/2008 | US20080155714 oil producing crop plant is produced by transfecting; efficient production of cyclopropane fatty acids in an oilseed crop; forming biodegradable lubricants from plant oil; intermediates to branched fatty acids with the low temperature properties and resist to oxidation |
| 06/26/2008 | US20080155713 Lipid Metabolic and Signalling Pathways in the Epidermis |
| 06/26/2008 | US20080155712 Means for identifying nucleotide sequences involved in apomixis |
| 06/26/2008 | US20080155711 Cotton variety st 5327b2rf |
| 06/26/2008 | US20080155710 Cotton variety st 4427b2rf |
| 06/26/2008 | US20080155708 novel cotton variety designated STX0502RF. Provided by the invention are the seeds, plants, plant parts and derivatives of the cotton variety STX0502RF. Also provided by the invention are tissue cultures of the cotton variety STX0502RF and the plants regenerated therefrom. |
| 06/26/2008 | US20080155707 novel cotton variety designated STX0502RF. Provided by the invention are the seeds, plants, plant parts and derivatives of the cotton variety STX0502RF. Also provided by the invention are tissue cultures of the cotton variety STX0502RF and the plants regenerated therefrom. |
| 06/26/2008 | US20080154386 Method of making demineralized bone particles |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153772 Oligonucleotides For Rna Interference and Biological Applications Thereof |
| 06/26/2008 | US20080153770 Expression Vectors with Improved Safety |
| 06/26/2008 | US20080153767 Modulation of forkhead box o1a expression |
| 06/26/2008 | US20080153765 Inducing apoptosis in a bcl-6-expressing cell or a non-Hodgkin's lymphoma cell; nucleic acid molecule having a sequence corresponding to or complementary to accessible regions of bcl-6 mRNA, vectors, cells, |
| 06/26/2008 | US20080153764 Used in cells and transgenic animals for a variety of applications including producing and studying the effects of RNAi and microRNA mediated gene silencing. |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153749 Methods and compositions for cell-cycle regulation |
| 06/26/2008 | US20080153745 Compositions of tRNA and uses thereof |
| 06/26/2008 | US20080153167 In vivo amplification of neural progenitor cells |
| 06/26/2008 | US20080153165 Use of plant tissue culture medium containing enriched concentration of thiamine, sacarose, kinetine, adenine, 2,4diclorofenoxiacetico (2,4D), L-Glutamine, cysteine, ascorbic acid, and Gelrite (reg); production of biomass by directly culturing seed kernel differentiated tissue |
| 06/26/2008 | US20080153164 Iscove's Modified Dubellco's Medium, Fetal calf and Horse serums, L-Glutamin, Penicillin/Streptomycin, Hu-R Bone Morphogenetic Protein 2, Hu-R Fibroblast Growth Factor 2, Hu-R Vascular Endothelial Growth Factor; enables growth in vitro of endothelial, myocardiac progenitor cells from CD34+ cells |
| 06/26/2008 | US20080153163 Compositions and methods for the expansion and differentiation of stem cells |
| 06/26/2008 | US20080153161 Genetically Encoded Photosensitizers and Methods for Using Same |
| 06/26/2008 | US20080153160 Human malignant cystosarcoma phyllodes derived mouse cell line and its applications |
| 06/26/2008 | US20080153159 Therapeutic and diagnostic agents |
| 06/26/2008 | US20080153158 Melting material for use in tissue processing by placing it in solid form into bath and heating, where material has volume substantially similar in both melted and solid forms, that equates to predetermined fill volume of bath sufficient for required automatic tissue processing of samples for diagnosis |
| 06/26/2008 | US20080153157 Method of obtaining viable small tissue particles and use for tissue repair |
| 06/26/2008 | US20080153141 nucleotide sequence encoding a polypeptide Delta 9 desaturase enzyme which has the ability to convert palmitic acid or stearic acid into palmitoleic acid or oleic acid respectively |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153120 Salt Taste Receptor and its Use in an Assay for Salt Taste |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080153101 Compositions and methods for identifying agents that alter expression of survivin |
| 06/26/2008 | US20080153087 Measuring refracted non-fluorescent light using phase contrast or Dark field optical system; distinguish X and Y chromosome-bearing sperm for in vitro fertilization |
| 06/26/2008 | US20080153077 Resemble in vivo three-dimensional matrices; networks of nanofibers and base substrate of a non-woven or woven porous substrate; use as scaffold for tissue engineering, in drug bioassay, cell culturing, immobilization of compounds from solution such as sort/purify a population of cells |
| 06/26/2008 | US20080152737 Plant extracts; cosmetics; galactolipids |
| 06/26/2008 | US20080152684 Having pesticidal activity and being antagonistic against bacterial pathogens and fungal pathogens of Pythium, Rhizoctonia, Colletotrichum , and Sclerotium; plant diseases |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |